116 related articles for article (PubMed ID: 6316106)
1. Characterization of solubilized opiate receptors from human placenta.
Ahmed MS
Membr Biochem; 1983; 5(1):35-47. PubMed ID: 6316106
[TBL] [Abstract][Full Text] [Related]
2. Opiate receptor subtypes in the rat hypothalamus and neurointermediate lobe.
Stojilković SS; Dufau ML; Catt KJ
Endocrinology; 1987 Jul; 121(1):384-94. PubMed ID: 3036471
[TBL] [Abstract][Full Text] [Related]
3. Opioid binding properties of the purified kappa receptor from human placenta.
Ahmed MS; Zhou DH; Cavinato AG; Maulik D
Life Sci; 1989; 44(13):861-71. PubMed ID: 2538693
[TBL] [Abstract][Full Text] [Related]
4. Solubilization and preliminary characterization of mu and kappa opiate receptor subtypes from rat brain.
Chow T; Zukin RS
Mol Pharmacol; 1983 Sep; 24(2):203-12. PubMed ID: 6310362
[TBL] [Abstract][Full Text] [Related]
5. Characterization of human placental opioid receptors by 3H-ethylketocyclazocine and 3H-naloxone binding.
Agbas A; Simon J; Avni Oktem H; Varga E; Borsodi A
Neuropeptides; 1988 Oct; 12(3):171-6. PubMed ID: 2907370
[TBL] [Abstract][Full Text] [Related]
6. Kappa opiate binding sites in human placenta.
Porthé G; Valette A; Cros J
Biochem Biophys Res Commun; 1981 Jul; 101(1):1-6. PubMed ID: 6116490
[No Abstract] [Full Text] [Related]
7. Interaction between [3H]ethylketocyclazocine and [3H]etorphine and opioid receptors in membranes from rat brain. A kinetic analysis.
Fischel SV; Medzihradsky F
Neuropharmacology; 1986 Apr; 25(4):351-9. PubMed ID: 3012397
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of opioid receptors in guinea-pig cerebellum and human placenta.
Ishizuka Y; Oka T; Kenjo T; Fujii A
Tokai J Exp Clin Med; 1986 Aug; 11(3):179-84. PubMed ID: 3039693
[TBL] [Abstract][Full Text] [Related]
9. Modulation of rat brain opioid receptors by cannabinoids.
Vaysse PJ; Gardner EL; Zukin RS
J Pharmacol Exp Ther; 1987 May; 241(2):534-9. PubMed ID: 3033219
[TBL] [Abstract][Full Text] [Related]
10. Photoaffinity labeling of opiate receptors using intrinsically photoactive 3H-opiates.
Kooper GN; Levinson NR; Copeland CF; Bowen WD
Mol Pharmacol; 1988 Mar; 33(3):316-26. PubMed ID: 2832721
[TBL] [Abstract][Full Text] [Related]
11. Evidence for multiple "Kappa" binding sites by use of opioid peptides in the guinea-pig lumbo-sacral spinal cord.
Attali B; Gouardères C; Mazarguil H; Audigier Y; Cros J
Neuropeptides; 1982 Oct; 3(1):53-64. PubMed ID: 6296719
[TBL] [Abstract][Full Text] [Related]
12. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes.
Puttfarcken P; Werling LL; Brown SR; Cote TE; Cox BM
Mol Pharmacol; 1986 Aug; 30(2):81-9. PubMed ID: 3016503
[TBL] [Abstract][Full Text] [Related]
13. Resolution in the receptor binding of putative mu and kappa opiates.
Medzihradsky F; Dahlstrom PJ; Woods JH; Fischel SV; Mitsos SE
Life Sci; 1984 May; 34(22):2129-38. PubMed ID: 6145076
[TBL] [Abstract][Full Text] [Related]
14. Purification of a kappa-opioid receptor subtype from frog brain.
Simon J; Benyhe S; Hepp J; Khan A; Borsodi A; Szücs M; Medzihradszky K; Wollemann M
Neuropeptides; 1987 Jul; 10(1):19-28. PubMed ID: 2890119
[TBL] [Abstract][Full Text] [Related]
15. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
Meunier JC; Kouakou Y; Puget A; Moisand C
Mol Pharmacol; 1983 Jul; 24(1):23-9. PubMed ID: 6306437
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of opioid receptor binding in brain slices.
Barchfeld-Rothschild CC; Medzihradsky F
J Neurosci Res; 1987; 18(2):358-65. PubMed ID: 2891857
[TBL] [Abstract][Full Text] [Related]
17. Specific, high affinity [3H]ethylketocyclazocine binding in rat central nervous system: lack of evidence for kappa receptors.
Hiller JM; Simon EJ
J Pharmacol Exp Ther; 1980 Sep; 214(3):516-9. PubMed ID: 6249910
[TBL] [Abstract][Full Text] [Related]
18. [3H]Mr 2034 labels a high affinity opioid kappa-receptor not accessible to naloxazone.
Ensinger HA
Eur J Pharmacol; 1983 Apr; 89(1-2):143-7. PubMed ID: 6305681
[TBL] [Abstract][Full Text] [Related]
19. Physical separation of the agonist and antagonist forms of a mu opiate receptor?
Jauzac P; Puget A; Meunier JC
Life Sci; 1983; 33 Suppl 1():195-8. PubMed ID: 6319859
[TBL] [Abstract][Full Text] [Related]
20. Kappa opioid receptors in human lumbo-sacral spinal cord.
Gouardères C; Kopp N; Cros J; Quirion R
Brain Res Bull; 1986 Mar; 16(3):355-61. PubMed ID: 3011219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
